Endometrial ablation with the Cavaterm™ thermal balloon

Abstract

This prospective observational study evaluates the efficacy and safety of thermal Balloon endometrial ablation using the Cavaterm system for the treatment of dysfunctional uterine bleeding. Seventy-seven women with a mean age of 43 years who met the inclusion and exclusion criteria were treated under general anaesthesia. A 9-mm diameter catheter with a silicone balloon at its tip was inserted transcervically into the uterus and was inflated with sterile 1.5% glycine and connected to a control unit that maintained the temperature of the circulating heated fluid at 75 degrees C, monitored the pressure and terminated the treatment after 15 minutes. There were no intra-operative complications and patients tolerated the treatment well. Satisfaction rates were 90% at both 12 and 24 months. At 24 months 10% of patients had heavy periods, 5% normal periods, 39% light periods and 46% amenorrhoea. Cavaterm balloon ablation seems a safe and effective option for women with menorrhagia. The procedure does not require additional training and expertise in operative hysteroscopy and compares favourably with established techniques.